{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:34Z","timestamp":1787028574004,"version":"build-2736575974"},"reference-count":71,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) closely interacts with host cellular mechanisms, with mitochondria playing a crucial role in this process. As essential organelles that control cellular energy production, apoptosis, reactive oxygen species (ROS) metabolism, and innate immune responses, mitochondria are vital to the development of COVID-19. However, the exact molecular interactions between mitochondria and SARS-CoV-2 remain under active investigation. Gaining a comprehensive understanding of mitochondrial involvement in SARS-CoV-2 infection is therefore essential for uncovering complex disease mechanisms, identifying prognostic biomarkers, and developing effective treatments. Ultimately, exploring these virus\u2013host interactions may provide new insights into the fundamental and complex aspects of mitochondrial physiology and pathophysiology.<\/jats:p>","DOI":"10.3390\/ijms26209885","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T16:13:03Z","timestamp":1760717583000},"page":"9885","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanisms of Mitochondrial Impairment by SARS-CoV-2 Proteins: A Nexus of Pathogenesis with Significant Biochemical and Clinical Implications"],"prefix":"10.3390","volume":"26","author":[{"given":"Marco","family":"Refrigeri","sequence":"first","affiliation":[{"name":"Clinical Pathology Department, Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tola","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Ospedale \u201cGiovanni Paolo II\u201d, 07026 Olbia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosangela","family":"Mogavero","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Michela","family":"Pietracupa","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gionta","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9425-8293","authenticated-orcid":false,"given":"Roberto","family":"Scatena","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2023, January 15). WHO Coronavirus (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Chilamakuri, R., and Agarwal, S. (2021). COVID-19: Characteristics and Therapeutics. Cells, 10.","DOI":"10.3390\/cells10020206"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Denaro, M., Ferro, E., Barrano, G., Meli, S., Busacca, M., Corallo, D., Capici, A., Zisa, A., Cucuzza, L., and Gradante, S. (2023). Monitoring of SARS-CoV-2 Infection in Ragusa Area: Next Generation Sequencing and Serological Analysis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054742"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and Evolution of Pathogenic Coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41587-022-01474-0","article-title":"A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19","volume":"41","author":"Zhou","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chen, Z., Wang, C., Feng, X., Nie, L., Tang, M., Zhang, H., Xiong, Y., Swisher, S.K., Srivastava, M., and Chen, J. (2021). Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis. EMBO J., 40.","DOI":"10.15252\/embj.2021107776"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Brant, A.C., Tian, W., Majerciak, V., Yang, W., and Zheng, Z.-M. (2021). SARS-CoV-2: From its discovery to genome structure, transcription, and replication. Cell Biosci., 11.","DOI":"10.1186\/s13578-021-00643-z"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Mariano, G., Farthing, R.J., Lale-Farjat, S.L.M., and Bergeron, J.R.C. (2020). Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.605236"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"165878","DOI":"10.1016\/j.bbadis.2020.165878","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis, and therapies: Structural genomics approach","volume":"1866","author":"Naqvi","year":"2020","journal-title":"BBA Mol. Basis Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1348-0421.13157","article-title":"Involvement of SARS-CoV-2 accessory proteins in immunopathogenesis","volume":"68","author":"Ito","year":"2024","journal-title":"Microbiol Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.tibs.2021.06.001","article-title":"Cell entry by SARS-CoV-2","volume":"46","author":"Peng","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Huynh, T.V., Rethi, L., Lee, T.W., Higa, S., Kao, Y.H., and Chen, Y.J. (2023). Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19. Cells, 12.","DOI":"10.3390\/cells12060877"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kulkovien\u0117, G., Narauskait\u0117, D., Tunaityt\u0117, A., Volkevi\u010di\u016bt\u0117, A., Balion, Z., Kutakh, O., Ge\u010dys, D., Kairyt\u0117, M., Uldukyt\u0117, M., and Stankevi\u010dius, E. (2024). Differential Mitochondrial, Oxidative Stress and Inflammatory Responses to SARS-CoV-2 Spike Protein Receptor Binding Domain in Human Lung Microvascular, Coronary Artery Endothelial and Bronchial Epithelial Cells. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063188"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Keturakis, V., Narauskait\u0117, D., Balion, Z., Ge\u010dys, D., Kulkovien\u0117, G., Kairyt\u0117, M., \u017dukauskait\u0117, I., Benetis, R., Stankevi\u010dius, E., and Jekabsone, A. (2023). The Effect of SARS-CoV-2 Spike Protein RBD-Epitope on Immunometabolic State and Functional Performance of Cultured Primary Cardiomyocytes Subjected to Hypoxia and Reoxygenation. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316554"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yeung-Luk, B.H., Narayanan, G.A., Ghosh, B., Wally, A., Lee, E., Mokaya, M., Wankhade, E., Zhang, R., Lee, B., and Park, B. (2023). SARS-CoV-2 infection alters mitochondrial and cytoskeletal function in human respiratory epithelial cells mediated by expression of spike protein. mBio, 14.","DOI":"10.1128\/mbio.00820-23"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s11010-022-04593-z","article-title":"Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: A comprehensive evidential insight","volume":"478","author":"Bhowal","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"De Nicolo, B., Cataldi-Stagetti, E., Diquigiovanni, C., and Bonora, E. (2023). Calcium and Reactive Oxygen Species Signaling Interplays in Cardiac Physiology and Pathologies. Antioxidants, 12.","DOI":"10.3390\/antiox12020353"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41375-020-0887-9","article-title":"SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine \u201cstorm\u201d and risk factor for damage of hematopoietic stem cells","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Guarnieri, J.W., Angelin, A., Murdock, D.G., Schaefer, P., Portluri, P., Lie, T., Huang, J., and Wallace, D.C. (2023). SARS-COV-2 viroporins activate the NLRP3-inflammasome by the mitochondrial permeability transition pore. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1064293"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.smhs.2023.03.004","article-title":"More than a key\u2014The pathological roles of SARS-CoV-2 spike protein in COVID-19 related cardiac injury","volume":"6","author":"Lin","year":"2023","journal-title":"Sports Med. Health Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","article-title":"A structural analysis of M protein in coronavirus assembly and morphology","volume":"174","author":"Neuman","year":"2011","journal-title":"J. Struct. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","article-title":"The BCL2 family: From apoptosis mechanisms to new advances in targeted therapy","volume":"10","author":"Vogler","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ren, Y., Wang, A., Fang, Y., Shu, T., Wu, D., Wang, C., Huang, M., Min, J., Jin, L., and Zhou, W. (2021). SARS-CoV-2 Membrane Glycoprotein M Triggers Apoptosis With the Assistance of Nucleocapsid Protein N in Cells. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.706252"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Castillo-Gal\u00e1n, S., Gr\u00fcnenwald, F., Hidalgo, Y., C\u00e1rdenas, J.C., Cadiz, M.I., Alcayaga-Miranda, F., Khoury, M., and Cuenca, J. (2025). Mitochondrial Antiviral Signaling Protein Activation by Retinoic Acid-Inducible Gene I Agonist Triggers Potent Antiviral Defense in Umbilical Cord Mesenchymal Stromal Cells Without Compromising Mitochondrial Function. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104686"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Duan, X., Liu, R., Lan, W., and Liu, S. (2025). The Essential Role of Mitochondrial Dynamics in Viral Infections. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26051955"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chen, T.H., Jeng, T.H., Lee, M.Y., Wang, H.C., Tsai, K.F., and Chou, C.K. (2025). Viral mitochondriopathy in COVID-19. Redox Biol., 85.","DOI":"10.1016\/j.redox.2025.103766"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"120981","DOI":"10.1016\/j.lfs.2022.120981","article-title":"SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response","volume":"308","author":"Hsu","year":"2022","journal-title":"Life Sci."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Cui, X., Chen, W., Zhou, H., Gong, Y., Zhu, B., Lv, X., Guo, H., Duan, J., Zhou, J., and Marcon, E. (2021). Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.664349"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40035-024-00458-1","article-title":"SARS-CoV-2 membrane protein induces neurodegeneration via affecting Golgi-mitochondria interaction","volume":"13","author":"Wang","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41418-022-00928-x","article-title":"SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK","volume":"29","author":"Yang","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Guarnieri, J.W., Lie, T., Albrecht, Y.E.S., Hewin, P., Jurado, K.A., Widjaja, G.A., Zhu, Y., McManus, M.J., Kilbaugh, T.J., and Keith, K. (2024). Mitochondrial antioxidants abate SARS-COV-2 pathology in mice. Proc. Natl. Acad. Sci. USA, 121.","DOI":"10.1073\/pnas.2321972121"},{"key":"ref_32","unstructured":"(2025, August 25). Detrimental Effects of Anti-Nucleocapsid Antibodies in COVID-19\u2014Thailand Medical News. Available online: https:\/\/www.thailandmedical.news\/news\/detrimental-effects-of-anti-nucleocapsid-antibodies-in-covid-19."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Yu, H., Yang, L., Han, Z., Zhou, X., Zhang, Z., Sun, T., Zheng, F., Yang, J., Guan, F., and Xie, J. (2023). SARS-CoV-2 nucleocapsid protein enhances the level of mitochondrial reactive oxygen species. J. Med. Virol., 95.","DOI":"10.1002\/jmv.29270"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Cao, Y., Wang, Y., Huang, D., and Tan, Y.-J. (2025). The Role of SARS-CoV-2 Nucleocapsid Protein in Host Inflammation. Viruses, 17.","DOI":"10.3390\/v17081046"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Georgieva, E., Ananiev, J., Yovchev, Y., Arabadzhiev, G., Abrashev, H., Abrasheva, D., Atanasov, V., Kostandieva, R., Mitev, M., and Petkova-Parlapanska, K. (2023). COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914876"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gokhale, N.S., Sam, R.K., Somfleth, K., Thompson, M.G., Marciniak, D.M., Smith, J.R., Genoyer, E., Eggenberger, J., Chu, L.H., and Park, M. (2024). Cellular RNA interacts with MAVS to promote antiviral signaling. Science, 386.","DOI":"10.1126\/science.adl0429"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cytogfr.2021.06.002","article-title":"The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies","volume":"61","author":"Zhao","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1007\/s11357-024-01165-5","article-title":"Mitochondrial dysfunction in long COVID: Mechanisms, consequences, and potential therapeutic approaches","volume":"46","author":"Molnar","year":"2024","journal-title":"Geroscience"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Chen, T.H., Chang, C.J., and Hung, P.H. (2023). Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098034"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Tang, N., Kido, T., Shi, J., McCafferty, E., Ford, J.M., Dal Bon, K., and Pulliam, L. (2024). Blood Markers Show Neural Consequences of LongCOVID-19. Cells, 13.","DOI":"10.20944\/preprints202402.0892.v1"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zhou, S., Lv, P., Li, M., Chen, Z., Xin, H., Reilly, S., and Zhang, X. (2023). SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development. Biomed. Pharmacother., 159.","DOI":"10.1016\/j.biopha.2023.114242"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-022-00884-5","article-title":"Structural biology of SARS-CoV-2: Open the door for novel therapies","volume":"7","author":"Yan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mehregan, A., P\u00e9rez-Conesa, S., Zhuang, Y., Elbahnsi, A., Pasini, D., Lindahl, E., Howard, R.J., Ulens, C., and Delemotte, L. (2022). Probing effects of the SARS-CoV-2 E protein on membrane curvature and intracellular calcium. Biochim. Biophys. Acta Biomembr., 1864.","DOI":"10.1101\/2021.05.28.446179"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Alvarez, F., de Melo, G.D., Larrous, F., Kergoat, L., Bo\u00ebda, B., Michel, V., Seilhean, D., Tichit, M., Hing, D., and Hardy, D. (2025). The SARS-CoV-2 envelope PDZ binding motif acts as a virulence factor disrupting host\u2019s epithelial cell\u2014Cell junctions. Cell. Mol. Biol. Lett., 30.","DOI":"10.1186\/s11658-025-00758-y"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Mishra, S.R., Mahapatra, K.K., Behera, B.P., Patra, S., Bhol, C.S., Panigrahi, D.P., Praharaj, P.P., Singh, A., Patil, S., and Dhiman, R. (2021). Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics. Int. J. Biochem. Cell Biol., 136.","DOI":"10.1016\/j.biocel.2021.106013"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12964-023-01104-5","article-title":"Structural and non-structural proteins in SARS-CoV-2: Potential aspects to COVID-19 treatment or prevention of progression of related diseases","volume":"21","author":"Kakavandi","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Low, Z.Y., Zabidi, N.Z., Yip, A.J.W., Puniyamurti, A., Chow, V.T.K., and Lal, S.K. (2022). SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion. Viruses, 14.","DOI":"10.3390\/v14091991"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.1038\/s41467-023-43666-5","article-title":"SARS-CoV-2 nsp3 and nsp4 are minimal constituents of a pore spanning replication organelle","volume":"14","author":"Zimmermann","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-022-00878-3","article-title":"SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules","volume":"7","author":"Zheng","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"107774","DOI":"10.1016\/j.celrep.2020.107774","article-title":"Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2","volume":"31","author":"Peng","year":"2020","journal-title":"Cell Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1038\/s41467-021-25166-6","article-title":"Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase","volume":"12","author":"Newman","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00018-025-05822-6","article-title":"The P132H mutation of SARS-CoV-2 NSP5 relieves its inhibition on interferon-\u03b2 activation via blocking MAVS degradation","volume":"82","author":"Zhang","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The \u2018cytokine storm\u2019: Molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.20517\/jca.2023.50","article-title":"Dysfunctional mitochondria elicit bioenergetic decline in the aged heart","volume":"4","author":"Mone","year":"2024","journal-title":"J. Cardiovasc. Aging"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Nunn, A.V.W., Guy, G.W., Brysch, W., and Bell, J.D. (2022). Understanding Long COVID; Mitochondrial Health and Adaptation\u2014Old Pathways, New Problems. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123113"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"109428","DOI":"10.1016\/j.intimp.2022.109428","article-title":"Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options","volume":"113","author":"Nazerian","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","article-title":"The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications","volume":"127","author":"McFadyen","year":"2020","journal-title":"Circ. Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Clemente-Su\u00e1rez, V.J., Redondo-Fl\u00f3rez, L., Beltr\u00e1n-Velasco, A.I., Ramos-Campo, D.J., Belinch\u00f3n-deMiguel, P., Martinez-Guardado, I., Dalamitros, A.A., Y\u00e1\u00f1ez-Sep\u00falveda, R., Mart\u00edn-Rodr\u00edguez, A., and Tornero-Aguilera, J.F. (2023). Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities. Biomedicines, 11.","DOI":"10.3390\/biomedicines11092488"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Redondo, N., Zald\u00edvar-L\u00f3pez, S., Garrido, J.J., and Montoya, M. (2021). SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.708264"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Zandi, M., Shafaati, M., Kalantar-Neyestanaki, D., Pourghadamyari, H., Fani, M., Soltani, S., Kaleji, H., and Abbasi, S. (2022). The role of SARS-CoV-2 accessory proteins in immune evasion. Biomed. Pharmacother., 156.","DOI":"10.1016\/j.biopha.2022.113889"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"106280","DOI":"10.1016\/j.isci.2023.106280","article-title":"Coronavirus accessory protein ORF3 biology and its contribution to viral behavior and pathogenesis","volume":"26","author":"Si","year":"2023","journal-title":"iScience"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"108080","DOI":"10.1016\/j.isci.2023.108080","article-title":"The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity","volume":"26","author":"Stewart","year":"2023","journal-title":"iScience"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"107118","DOI":"10.1016\/j.isci.2023.107118","article-title":"SARS-CoV-2 ORF3c impairs mitochondrial respiratory metabolism, oxidative stress, and autophagic flux","volume":"26","author":"Mozzi","year":"2023","journal-title":"iScience"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"28344","DOI":"10.1073\/pnas.2016650117","article-title":"SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling","volume":"117","author":"Miorin","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Wen, Y., Li, C., Tang, T., Luo, C., Lu, S., Lyu, N., Li, Y., and Wang, R. (2025). SARS-CoV-2 ORF7a Protein Impedes Type I Interferon-Activated JAK\/STAT Signaling by Interacting with HNRNPA2B1. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26125536"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Mansueto, G., Fusco, G., and Colonna, G. (2024). A Tiny Viral Protein, SARS-CoV-2-ORF7b: Functional Molecular Mechanisms. Biomolecules, 14.","DOI":"10.20944\/preprints202403.0473.v1"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Flower, T.G., Buffalo, C.Z., Hooy, R.M., Allaire, M., Ren, X., and Hurley, J.H. (2021). Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Proc. Natl. Acad. Sci. USA, 118.","DOI":"10.1073\/pnas.2021785118"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Vinjamuri, S., Li, L., and Bouvier, M. (2022). SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1035559"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lenhard, S., Gerlich, S., Khan, A., R\u00f6dl, S., B\u00f6kenkamp, J.E., Peker, E., Zarges, C., Faust, J., Storchova, Z., and R\u00e4schle, M. (2023). The Orf9b protein of SARS-CoV-2 modulates mitochondrial protein biogenesis. J. Cell Biol., 222.","DOI":"10.1083\/jcb.202303002"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Dominguez Andres, A., Feng, Y., Campos, A.R., Yin, J., Yang, C.C., James, B., Murad, R., Kim, H., Deshpande, A.J., and Gordon, D.E. (2020). SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells. bioRxiv.","DOI":"10.1101\/2020.08.18.256776"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41423-021-00807-4","article-title":"SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy","volume":"19","author":"Li","year":"2022","journal-title":"Cell. Mol. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/20\/9885\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T16:18:10Z","timestamp":1760717890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/20\/9885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":71,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["ijms26209885"],"URL":"https:\/\/doi.org\/10.3390\/ijms26209885","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]}}}